enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Brett Favre's Parkinson's diagnosis reignites questions about ...

   www.aol.com/news/brett-favres-parkinsons...

   The Summary. Brett Favre revealed Tuesday that he has Parkinson's disease. Early research has established a likely link between contact sports like football and Parkinson’s, as well as ...

3. NIH cuts put medical research at risk, scientists say ... - AOL

   www.aol.com/news/nih-cuts-put-medical-research...

   Each year, the National Institutes of Health gives billions of dollars to the University of California to pay for research into cancer, Alzheimer's, Parkinson's, heart disease, diabetes and other ...

4. Patrik Brundin - Wikipedia

   en.wikipedia.org/wiki/Patrik_Brundin

   Patrik Brundin (born December 26, 1961, in Malmö, Sweden) is a neuroscientist known for his research on Parkinson's disease (PD) and Huntington's disease. [1] [2] [3] He is currently a Distinguished Scientist and serving as Therapeutic Area Leader for Movement Disorders at F. Hoffmann-La Roche, Pharmaceutical Research and Early Development (pRED).

5. Research in Parkinson's disease - Wikipedia

   en.wikipedia.org/wiki/Research_in_Parkinson's...

   The research in Parkinson's disease (also known as clinical trials, medical research, research studies, or clinical studies) refers to any study intended to help answer questions about etiology, diagnostic approaches or new treatments of Parkinson's disease (PD) by studying their effects on human subjects.

6. Bagadilico - Wikipedia

   en.wikipedia.org/wiki/Bagadilico

   The group's ultimate goal is to find new therapies for Parkinson's disease and Huntington's disease. These disorders have in common that they are caused by disturbances in the part of the brain called the basal ganglia. To achieve this goal, the group wants to establish and develop a strong, multidisciplinary research environment.

7. US FDA declines to approve Supernus' Parkinson's ... - AOL

   www.aol.com/news/u-fda-declines-approve-supernus...

   (Reuters) - Supernus Pharmaceuticals said on Monday the U.S. FDA declined to approve its drug-device combination to treat movement-related symptoms of Parkinson's disease, sending its shares down ...